Read the latest NeoGenomics press releases and updates here.
To follow our news, sign up for NeoNEWS, our email newsletter.
September 25, 2019
NeoGenomics To Present At 2019 Cantor Global Healthcare Conference
September 3, 2019
NeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences
August 8, 2019
NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance
July 31, 2019
NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore
July 30, 2019
NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter
July 9, 2019
NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida
July 1, 2019
NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019
June 27, 2019
NeoGenomics Announces New $250 Million Credit Agreement
May 30, 2019
NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference
May 23, 2019
NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference
May 21, 2019
NeoGenomics Announces Pricing on Public Offering of Common Stock
May 20, 2019
NeoGenomics Announces Proposed Public Offering of Common Stock
April 30, 2019
NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
April 3, 2019
NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019
April 2, 2019
NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference
March 7, 2019
NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
February 19, 2019
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
January 28, 2019
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
December 13, 2018
NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer
December 10, 2018
NeoGenomics Completes Acquisition of Genoptix, Inc.
November 30, 2018
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
October 30, 2018
NeoGenomics Reports 17% Revenue Growth to Record $69 Million
October 23, 2018
NeoGenomics Signs Definitive Agreement to Acquire Genoptix
September 24, 2018
NeoGenomics Announces Participation in NCI-MATCH Clinical Trial
September 12, 2018
NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier
August 9, 2018
NeoGenomics Announces Pricing on Public Offering of Common Stock
August 6, 2018
NeoGenomics Announces Proposed Public Offering of Common Stock
July 2, 2018
NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018
June 25, 2018
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock
June 1, 2018
PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions
May 25, 2018
NeoGenomics to Participate In Two Upcoming Investor Conferences
April 2, 2018
NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018
March 20, 2018
NeoGenomics Announces Executive Appointments
February 21, 2018
NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017
January 30, 2018
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018
December 31, 2017
NeoGenomics Featured in the Canton of Vaud Annual Report
December 6, 2017
NeoGenomics Announces Six Clinical Data Presentations to be Given at the American Society of Hematology Meeting
December 5, 2017
NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine™ Dx Target Test
November 9, 2017
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials
October 25, 2017
NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017
October 24, 2017
NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials
October 12, 2017
NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance
September 28, 2017
NeoGenomics Schedules its Q3 2017 Earnings Release for October 25, 2017
September 11, 2017
NeoGenomics Reports on Impacts from Hurricane Irma
June 28, 2017
NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017
June 2, 2017
NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests
April 26, 2017
NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017
April 20, 2017
NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
April 14, 2017
NeoGenomics Schedules its Q1 2017 Earnings Release for April 26, 2017
March 13, 2017
NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing
February 22, 2017
NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
February 8, 2017
NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017
December 22, 2016
NeoGenomics Closes $150 Million Senior Credit Facility
October 26, 2016
NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016
October 11, 2016
NeoGenomics Schedules its Q3 2016 Earnings Release for October 26, 2016
Jul 5, 2016
NeoGenomics Schedules its Q2 2016 Earnings Release for July 26, 2016
Apr 11, 2016
NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016
Jan 26, 2016
NeoGenomics Schedules its Q4 2015 and Full Year 2015 Earnings Release for March 1, 2016
Dec 30, 2015
NeoGenomics Completes Acquisition of Clarient, Inc.
Oct 28, 2015
NeoGenomics Amends Strategic Alliance Agreement with Covance Central Laboratory Services
Oct 21, 2015
NeoGenomics Signs Definitive Agreement to Acquire Clarient, Inc.
Oct 12, 2015
NeoGenomics Schedules its Q3 2015 Earnings Release for October 29, 2015
Sep 23, 2015
NeoGenomics Launches New NeoSITE™ Cervical FISH Assay for Evaluation of Abnormal Pap Tests